Prognosis
Moderna Submits Booster Data; Apple Worker Status: Virus Update
This article is for subscribers only.
Moderna Inc. submitted initial data on its booster shot to U.S. regulators. Pfizer Inc. dosed the first participant in a late-stage trial of its experimental oral antiviral treatment. Hospitalizations in the U.S. fell for the first time since June.
A majority of U.S. employers are planning or considering requirements for a Covid shot by year-end. Apple Inc. is asking all U.S. employees to report their vaccination status.